Leap Therapeutics Inc
NASDAQ:LPTX
Leap Therapeutics Inc
NASDAQ:LPTX
Price:
2.05
USD
368.57%
Market Closed
Market Cap:
$116.1m
Balance Sheet
Balance Sheet Decomposition
Leap Therapeutics Inc
Leap Therapeutics Inc
Balance Sheet Decomposition is not available for
Leap Therapeutics Inc
Leap Therapeutics Inc
Balance Sheet
Leap Therapeutics Inc
Leap Therapeutics Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
26
|
16
|
4
|
52
|
115
|
66
|
71
|
47
|
|
| Cash Equivalents |
0
|
0
|
1
|
26
|
16
|
4
|
52
|
115
|
66
|
71
|
47
|
|
| Total Receivables |
0
|
0
|
3
|
2
|
1
|
0
|
0
|
1
|
2
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
4
|
28
|
17
|
4
|
52
|
117
|
68
|
72
|
48
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
2
|
1
|
2
|
2
|
2
|
1
|
2
|
1
|
1
|
|
| Total Assets |
1
N/A
|
1
+11%
|
6
+412%
|
29
+350%
|
19
-34%
|
7
-61%
|
54
+630%
|
118
+117%
|
70
-40%
|
73
+4%
|
49
-33%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
1
|
2
|
3
|
3
|
4
|
5
|
3
|
4
|
6
|
6
|
5
|
|
| Accrued Liabilities |
1
|
0
|
3
|
3
|
3
|
4
|
3
|
6
|
6
|
6
|
9
|
|
| Short-Term Debt |
3
|
3
|
30
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
|
| Total Current Liabilities |
5
|
6
|
36
|
6
|
6
|
8
|
7
|
10
|
11
|
13
|
14
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
12
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
5
N/A
|
6
+21%
|
36
+538%
|
18
-50%
|
10
-45%
|
9
-7%
|
8
-16%
|
10
+30%
|
11
+15%
|
13
+10%
|
14
+11%
|
|
| Equity | ||||||||||||
| Common Stock |
33
|
66
|
71
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
37
|
70
|
101
|
130
|
154
|
195
|
223
|
264
|
318
|
400
|
467
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
142
|
162
|
193
|
270
|
372
|
377
|
460
|
503
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
4
-25%
|
30
-574%
|
11
N/A
|
9
-17%
|
2
N/A
|
47
N/A
|
108
+131%
|
59
-45%
|
60
+2%
|
35
-42%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
+11%
|
6
+412%
|
29
+350%
|
19
-34%
|
7
-61%
|
54
+630%
|
118
+117%
|
70
-40%
|
73
+4%
|
49
-33%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
2
|
6
|
9
|
10
|
26
|
38
|
|
Switch to:
Switch to:
See Also
Discover More
